INDIANAPOLIS (dpa-AFX) - Aquinox Pharmaceuticals Inc. (AQXP) is expanding
its ongoing phase II clinical trials with its lead product candidate, AQX-1125.
Accordingly, the company's phase II trial of AQX-1125 in reducing pain and
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/BioClinica+%28BIOC%29+Announces+Clinical+Trial+Efficiency+Improvements+with+Johnson+and+Johnson+Vision+Care/6724409.html for the full story.
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/BioClinica+%28BIOC%29+Posts+Q3+non-GAAP+EPS+of+%240.07%2C+Shy+YY%3B+Revs+Heavy%3B+Reaffirms+FY10+Outlook/6071947.html for the full story.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.